Duke MMIL designs novel SPECT/CT system for 3D breast imaging

Jul 17, 2007
2007 07 17 15 08 50 706
2007 07 17 15 08 50 706
Image courtesy of Duke University Medical Center Multi-Modality Imaging Lab.

Latest in Molecular Imaging
Heart Plaque
CAC score of 0 indicate low heart event risk, even in older people
March 29, 2025
Brain MRI and F-18 FDG brain and whole-body PET/CT images. (A) No obvious abnormalities were found in axial and sagittal slices from T2-weighted MR images. (B) Whole cerebellar cortex had diffuse F-18 FDG hypermetabolism in PET/CT brain images, with SUVmax of 25.91. (C and D) Whole-body F-18 FDG-PET/CT showing distended bladder. TLG = total lesion glycolysis; MTV = metabolic tumor volume. Image and caption courtesy of the Journal of Nuclear Medicine.
PET/CT visualizes extremely rare brain inflammation
March 27, 2025
Imaging Life Issue 20 now available
Sponsored
Imaging Life Issue 20 now available
April 1, 2025
2025 03 25 Fill States Thumbnail
New method proposed for diagnosing Alzheimer’s
March 25, 2025
Related Stories
2007 07 17 14 38 39 706
Molecular Imaging
Duke MMIL designs novel SPECT/CT system for 3D breast imaging
2007 07 17 14 32 28 706
Molecular Imaging
Duke MMIL designs novel SPECT/CT system for 3D breast imaging
2007 06 25 10 54 15 706
Molecular Imaging
Studies link Alzheimer's to beta-amyloid and potential for new ligand
Imaging Life Issue 20 now available
Sponsor Content
Imaging Life Issue 20 now available
More in Molecular Imaging
CAC score of 0 indicate low heart event risk, even in older people
By Kate Madden Yee
PET/CT imaging indicates that a coronary artery calcium (CAC) score of 0 is an accurate indicator of low coronary heart event risk even as a person ages, investigators have reported.
March 29, 2025
Heart Plaque
PET/CT visualizes extremely rare brain inflammation
By Will Morton
An F-18 FDG-PET/CT scan proved crucial in identifying an ultrarare case of brain inflammation in a patient due to the flu.
March 27, 2025
Brain MRI and F-18 FDG brain and whole-body PET/CT images. (A) No obvious abnormalities were found in axial and sagittal slices from T2-weighted MR images. (B) Whole cerebellar cortex had diffuse F-18 FDG hypermetabolism in PET/CT brain images, with SUVmax of 25.91. (C and D) Whole-body F-18 FDG-PET/CT showing distended bladder. TLG = total lesion glycolysis; MTV = metabolic tumor volume. Image and caption courtesy of the Journal of Nuclear Medicine.
Targeted alpha therapy’s ‘elite 8’ radionuclides
By Will Morton
A select group of eight radionuclides holds hopes for an emerging cancer treatment in nuclear medicine called targeted alpha therapy (TAT).
March 26, 2025
Isotopes1
New method proposed for diagnosing Alzheimer’s
By Will Morton
Researchers in Germany have proposed a new approach derived from brain PET imaging for diagnosing and staging Alzheimer’s disease.
March 25, 2025
2025 03 25 Fill States Thumbnail
Whole-body PET visualizes COVID-19 infection
By Will Morton
Researchers in France have developed a PET imaging approach for longitudinal tracking of the virus that causes COVID-19.
March 24, 2025
2025 03 24 Covid Brain Thumbnail
PSMA PET/CT identifies 'atypical' metastases in prostate cancer patients
By Will Morton
PET/CT scans with an experimental PSMA imaging agent can identify supraclavicular nodal metastasis in newly diagnosed prostate cancer patients.
March 21, 2025
F-18 PSMA-1007 PET/CT of a 70 year old with newly diagnosed prostate cancer: PSA 770 ng/ml; Gleason 5 + 5; International Society of Urological Pathology grade 5. The maximum intensity projection images, CT, and fused images show PSMA ligand-avid prostate primary with pelvic, retroperitoneal, and mediastinal nodal spread. Additionally, he had left supraclavicular nodal metastasis (arrows). Image and caption available for republishing under Creative Commons license (CC BY 4.0 DEED, Attribution 4.0 International) and courtesy of EJNMMI Reports.
IAEA touts radionuclide development activities
By Will Morton
The IAEA has highlighted its worldwide activities to meet increasing demands for alpha-emitting radionuclides for use in Targeted Alpha Therapy.
March 18, 2025
Isotopes1
FAPI-PET superior to FDG-PET for detecting bone cancer
By Will Morton
PET/CT imaging with fibroblast activation protein inhibitor (FAPI) detects more bone metastases than FDG-PET/CT in patients with different types of cancer.
March 17, 2025
Cancer Cell Target2
New analysis supports use of FES-PET in breast cancer patients
By Will Morton
F-18 fluoroestradiol (FES)-PET scans can predict whether endocrine therapy could be effective in women with estrogen receptor-positive breast cancer.
March 13, 2025
Fes Pet Abstract Thumbnail
What’s your brain like on a vanilla milkshake?
By Will Morton
A controlled “feeding” PET study by researchers at the National Institutes of Health (NIH) has called into question the theory that ultraprocessed foods elicit brain responses akin to addictive drugs.
March 12, 2025
Brain2
Hormone therapy linked to tau accumulation in older women
By Will Morton
A PET study reveals that women over the age of 70 who took menopausal hormone therapy more than a decade prior have faster brain tau accumulation.
March 7, 2025
Ad
Ac-225: From nuclear waste to cancer treatment
By Will Morton
U.S. Department of Energy (DOE) efforts to dispose of spent nuclear waste left over from the Cold War has turned into a boon for supplies of actinium-225 (Ac-225).
March 5, 2025
Isotopes1
Page 1 of 601
Next Page